Christopher joined Bristows as a trainee solicitor in August 2018 having worked in research and development for a global pharmaceutical company. He completed his training in September 2020 and joined the patent litigation team on qualification.

Christopher has a particular interest in patent litigation in the life sciences sector. He has worked on a number matters before the Patents Court (High Court) relating to small molecule drugs, monoclonal antibody drugs, pharmaceutical formulation and immunoassays. Christopher also assists with global patent litigation coordination projects and liaises closely with counsel and patent attorneys in a number of jurisdictions.